Cargando…
The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats
Background: Cancer remains a leading cause of death in companion animals. In human medicine, liposomes and nanoparticles have been extensively investigated as drug delivery systems (DDS) for anticancer agents due to their ability to target cancerous cells and reduce the negative side effects of free...
Autores principales: | Zabielska-Koczywąs, Katarzyna, Lechowski, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149801/ https://www.ncbi.nlm.nih.gov/pubmed/29215573 http://dx.doi.org/10.3390/molecules22122167 |
Ejemplares similares
-
Current knowledge on feline injection-site sarcoma treatment
por: Zabielska-Koczywąs, Katarzyna, et al.
Publicado: (2017) -
PEG-liposomal doxorubicin as a potential agent for canine metastatic osteosarcoma – in vitro and ex ovo studies
por: Walewska, Magdalena, et al.
Publicado: (2023) -
Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin—Preclinical Studies in a Murine Model
por: Zabielska-Koczywąs, Katarzyna, et al.
Publicado: (2018) -
Gold Nanoparticles Inhibit Extravasation of Canine Osteosarcoma Cells in the Ex Ovo Chicken Embryo Chorioallantoic Membrane Model
por: Małek, Anna, et al.
Publicado: (2023) -
Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma—In Vitro Studies
por: Małek, Anna, et al.
Publicado: (2021)